108 related articles for article (PubMed ID: 10379857)
1. Intraoperative gamma detection of 125I-lanreotide in women with primary breast cancer.
Cuntz MC; Levine EA; O'Dorisio TM; Watson JC; Wray DA; Espenan GD; McKnight C; Meier JR; Weber LJ; Mera R; O'Dorisio MS; Woltering EA
Ann Surg Oncol; 1999 Jun; 6(4):367-72. PubMed ID: 10379857
[TBL] [Abstract][Full Text] [Related]
2. Gamma-probe-guided resection of the sentinel lymph node in breast cancer.
Crossin JA; Johnson AC; Stewart PB; Turner WW
Am Surg; 1998 Jul; 64(7):666-8; discussion 669. PubMed ID: 9655279
[TBL] [Abstract][Full Text] [Related]
3. Sentinel lymph node mapping in early-stage breast cancer: technical issues and results with vital blue dye mapping and radioguided surgery.
Canavese G; Gipponi M; Catturich A; Di Somma C; Vecchio C; Rosato F; Percivale P; Moresco L; Nicolò G; Spina B; Villa G; Bianchi P; Badellino F
J Surg Oncol; 2000 May; 74(1):61-8. PubMed ID: 10861612
[TBL] [Abstract][Full Text] [Related]
4. Practical guidelines for optimal gamma probe detection of sentinel lymph nodes in breast cancer: results of a multi-institutional study. For the University of Louisville Breast Cancer Study Group.
Martin RC; Edwards MJ; Wong SL; Tuttle TM; Carlson DJ; Brown CM; Noyes RD; Glaser RL; Vennekotter DJ; Turk PS; Tate PS; Sardi A; Cerrito PB; McMasters KM
Surgery; 2000 Aug; 128(2):139-44. PubMed ID: 10922983
[TBL] [Abstract][Full Text] [Related]
5. Pilot study comparing the accuracy of lymphoscintigraphy sentinel lymph node localisation with axillary node dissection in women with operable breast cancer.
Allen B; Campbell I; Desai S; Dray M; Scarlet J
N Z Med J; 2001 May; 114(1132):233-6. PubMed ID: 11453361
[TBL] [Abstract][Full Text] [Related]
6. Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure.
Donker M; Straver ME; Wesseling J; Loo CE; Schot M; Drukker CA; van Tinteren H; Sonke GS; Rutgers EJ; Vrancken Peeters MJ
Ann Surg; 2015 Feb; 261(2):378-82. PubMed ID: 24743607
[TBL] [Abstract][Full Text] [Related]
7. Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable, or nonpalpable breast cancer.
Kumar R; Jana S; Heiba SI; Dakhel M; Axelrod D; Siegel B; Bernik S; Mills C; Wallack M; Abdel-Dayem HM
J Nucl Med; 2003 Jan; 44(1):7-10. PubMed ID: 12515869
[TBL] [Abstract][Full Text] [Related]
8. Somatostatin receptor in breast cancer and axillary nodes: study with scintigraphy, histopathology and receptor autoradiography.
Albérini JL; Meunier B; Denzler B; Devillers A; Tass P; Dazord L; Le Simple T; Laissue J; de Jong R; Le Cloirec J; Reubi JC; Bourguet P
Breast Cancer Res Treat; 2000 May; 61(1):21-32. PubMed ID: 10930087
[TBL] [Abstract][Full Text] [Related]
9. Lanreotide Autogel 90 mg and lymphorrhea prevention after axillary node dissection in breast cancer: a phase III double blind, randomized, placebo-controlled trial.
Gauthier T; Garuchet-Bigot A; Marin B; Mollard J; Loum O; Fermeaux V; Jammet I; Kanoun D; Maubon A; Aubard Y
Eur J Surg Oncol; 2012 Oct; 38(10):902-9. PubMed ID: 22703757
[TBL] [Abstract][Full Text] [Related]
10. Sentinel node biopsy in breast cancer.
Barnwell JM; Arredondo MA; Kollmorgen D; Gibbs JF; Lamonica D; Carson W; Zhang P; Winston J; Edge SB
Ann Surg Oncol; 1998 Mar; 5(2):126-30. PubMed ID: 9527265
[TBL] [Abstract][Full Text] [Related]
11. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection.
Borgstein PJ; Pijpers R; Comans EF; van Diest PJ; Boom RP; Meijer S
J Am Coll Surg; 1998 Mar; 186(3):275-83. PubMed ID: 9510258
[TBL] [Abstract][Full Text] [Related]
12. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
13. Detection of occult gastrinomas with iodine 125-labeled lanreotide and intraoperative gamma detection.
Woltering EA; Barrie R; O'Dorisio TM; O'Dorisio MS; Nance R; Cook DM
Surgery; 1994 Dec; 116(6):1139-46; discussion 1146-7. PubMed ID: 7985099
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer patients with extra-axillary sentinel nodes only may be spared axillary lymph node dissection.
van der Ploeg IM; Tanis PJ; Valdés Olmos RA; Kroon BB; Rutgers EJ; Nieweg OE
Ann Surg Oncol; 2008 Nov; 15(11):3239-43. PubMed ID: 18773244
[TBL] [Abstract][Full Text] [Related]
15. Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose-positron emission tomography: clinical evaluation and alternative management.
Greco M; Crippa F; Agresti R; Seregni E; Gerali A; Giovanazzi R; Micheli A; Asero S; Ferraris C; Gennaro M; Bombardieri E; Cascinelli N
J Natl Cancer Inst; 2001 Apr; 93(8):630-5. PubMed ID: 11309439
[TBL] [Abstract][Full Text] [Related]
16. Axillary ultrasound for preoperative nodal staging in breast cancer patients: is it of added value?
Schipper RJ; van Roozendaal LM; de Vries B; Pijnappel RM; Beets-Tan RG; Lobbes MB; Smidt ML
Breast; 2013 Dec; 22(6):1108-13. PubMed ID: 24095611
[TBL] [Abstract][Full Text] [Related]
17. [Axillary node removal in clinical node-negative breast carcinoma. Can its indication be individualized by "sentinel node" detection?].
Reuhl T; Kaisers H; Markwardt J; Haensch W; Hohenberger P; Schlag PM
Dtsch Med Wochenschr; 1998 May; 123(19):583-7. PubMed ID: 9618639
[TBL] [Abstract][Full Text] [Related]
18. [Lymph scintigraphy and pre- and intraoperative gamma probe measurements for localization of sentinel lymph nodes (SLN) in breast cancer].
Brenner W; Ostertag H; Czech N; zum Felde U; Kampen WU; Klutmann S; Bohuslavizki KH; Lüttges J; Sprenger A; Henze E
Nuklearmedizin; 2000; 39(3):82-7. PubMed ID: 10834196
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of intraoperative touch preparation analysis of sentinel lymph nodes for axillary metastasis in breast cancer.
Mullenix PS; Carter PL; Martin MJ; Steele SR; Scott CL; Walts MJ; Beitler AL
Am J Surg; 2003 May; 185(5):420-4. PubMed ID: 12727560
[TBL] [Abstract][Full Text] [Related]
20. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.
Veronesi U; Paganelli G; Galimberti V; Viale G; Zurrida S; Bedoni M; Costa A; de Cicco C; Geraghty JG; Luini A; Sacchini V; Veronesi P
Lancet; 1997 Jun; 349(9069):1864-7. PubMed ID: 9217757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
